Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements Meeting Abstract
| Authors: | Siena, S.; Drilon, A. E.; Ou, I. S. H.; Farago, A. F.; Patel, M.; Bauer, T. M.; Hong, D.; Liu, S. V.; Lee, J.; Patel, R.; Schechet, L.; Luo, D.; Maneval, E. C.; Multani, P. S.; De Braud, F. G. |
| Abstract Title: | Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S724 |
| End Page: | S725 |
| Language: | English |
| ACCESSION: | WOS:000361887403280 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)31947-5 |
| Notes: | Meeting Abstract: 29LBA -- Source: Wos |
